secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jazz Pharmaceuticals plc (JAZZ)
CIK:        0001232524
Form:       8-K
Filed at:   2024-02-27T23:59:59+00:00
Accession:  0001193125-24-047087
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Jazz Pharmaceuticals appoints Patrick Kennedy to Board; Peter Gray not standing for re-election
--------------------------------------------------------------------------------

- Patrick Kennedy appointed as Class I director effective March 1, 2024; term expires at 2024 AGM.
- Kennedy will serve on the Audit Committee; receives standard non-employee director compensation.
- Peter Gray notified the Board he will not stand for re-election at the 2024 Annual Meeting, with no disagreement with the Company.
- Kennedy entered into Jazz's standard indemnification agreement for directors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1232524/000119312524047087/0001193125-24-047087-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1232524/000119312524047087/d783837d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-047087

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer